• "Enteritis" diagnosis seemed obvious, but was wrong
• A 30-year-old industrial worker with upper back pain
• A 40-Year-Old Man with Sarcoidosis and Factor V Leiden Thrombophilia Presenting with Deep Vein Thrombosis and Pulmonary Thromboembolism
• A Case Report of Recurrent Severe Peripartum Cardiomyopathy Complicated by Factor V Leiden and Multiple Endocrine Neoplasia Type 1: A Management Conundrum
• A Genetic Origin? Purpura Fulminans
• A Giant Right Heart Thrombus-in-Transit: The Challenge of Anticoagulation in Factor V Leiden Thrombophilia
• A hybrid-system model of the coagulation cascade: simulation, sensitivity, and validation
• A Peculiar Case of Recurrent Coronary Artery Thrombosis
• A Right Middle Cerebral Artery Infarct After Frontal Eosinophilic Granuloma Resection in an 8-Year-Old Boy with Factor V Leiden
• Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women
• Activated protein C resistance assay and factor V Leiden
• Acute Myocardial Infarction in Patients with Hereditary Thrombophilia-A Focus on Factor V Leiden and Prothrombin G20210A
• Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer
• An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis
• Antiphopholipid antibodies and functional activated protein C resistance in patients with breast cancer during anthracycline-based chemotherapy administered through an intravenous port-catheter device
• Antiphospholipid syndrome's genetic and epigenetic aspects
• Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications
• Autoimmune coagulation factor V/5 deficiency during chronic disseminated intravascular coagulation
• Autoimmune-acquired coagulation factor V deficiency with hyperfibrinolytic disseminated intravascular coagulation
• Bilateral Kienbock's disease in a child with Factor V Leiden thrombophilia: a case report
• Bilateral Legg-Calve-Perthes Disease and Kienbock's Disease in a Child With Factor V Leiden Thrombophilia: A Case Report
• Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?
• Celiac artery embolism due to thrombophilia - a case report
• Cerebral embolism as an atypical presentation of May Thurner syndrome
• Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19
• Clinical Phenotype and Genetic Analysis of Twins With Congenital Coagulation Factor V Deficiency
• Clinical, radiological profile and prognostic role of transcranial color-coded duplex in cerebral venous thrombosis: a case-control study
• Combined and sequential use of activated protein C resistance and molecular genetic test for the diagnosis of factor V Leiden: a new laboratory approach
• Congenital anomaly of the inferior vena cava and factor V Leiden mutation predisposing to deep vein thrombosis
• Congenital coagulation factor V deficiency with intracranial hemorrhage
• Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs: cross-sectional single center study of prevalence and risk factors
• Edematous Colitis of an Unknown Cause, Diagnosis by Pattern Recognition
• Elucidation of an altered anticoagulant function due to Factor V abnormality and development of a simple screening assay for thrombophilia
• Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy
• Evaluation of Activated Protein C Resistance Using Thrombin Generation Test
• Evaluation of GenoFlow Thrombophilia Array Test Kit in its detection of mutations in Factor V Leiden (G1691A), prothrombin G20210A, MTHFR C677T and A1298C in blood samples from 113 Turkish female patients
• Extensive clot propagation involving the aorta and brachiocephalic artery: unusual consequence of paradoxical embolism
• Factor V Leiden
• Factor V Leiden
• Factor V Leiden and Cardiopulmonary Bypass
• Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study
• Factor V Leiden in women: a thrombotic risk factor or an evolutionary advantage?
• Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study
• Factor V Leiden mutation triggering four major complications to standard dose cisplatin-chemotherapy for testicular seminoma: a case report
• Factor V Leiden thrombophilia
• Factor V Leiden thrombophilia dental considerations
• Factor V leiden thrombophilia in a female collegiate soccer athlete: a case report
• Genetic risk factors for venous thromboembolism
• Hereditary thrombophilia
• High prevalence of thrombophilic risk factors in patients with central retinal artery occlusion
• Homozygous Factor V Leiden Thrombophilia in a Patient With Histologically Confirmed Thromboangiitis Obliterans
• Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study
• Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs
• Inherited Thrombophilia Associated With Ischemic Pediatric Stroke in Parent-Child Pairs
• Inherited Thrombophilia in a Lebanese Family of Four Generations: A Case Report of Recurrent Miscarriage
• Interaction of thrombophilic SNPs in patients with unexplained infertility-multifactor dimensionality reduction (MDR) model analysis
• Laboratory Testing for Activated Protein C Resistance (APCR): An Update
• Late failure of a split-thickness skin graft in the setting of homozygous factor V Leiden mutation: a case report and correlative animal model from the Wound Etiology and Healing (WE-HEAL) study
• Living Donor Liver Transplant in Patients With Budd-Chiari Syndrome: A Single-Center Experience at Our University Hospital
• Low molecular weight heparin modulates maternal immune response in pregnant women and mice with thrombophilia
• Magnetic resonance venography and genetics of a female patient with pelvic venous thrombosis
• Main Factors Predicting Nonresponders to Autologous Cell Therapy for Critical Limb Ischemia in Patients With Diabetic Foot
• Mean platelet volume as an effective biomarker for predicting high-risk patients of hereditary thrombophilia: A retrospective study
• Mesenteric vein thrombosis in a patient heterozygous for factor V Leiden and G20210A prothrombin genotypes
• Necessity and risks of arterial blood sampling in healthy volunteer studies
• Neonatal aortic arch thrombosis: analysis of thrombophilic risk factors and prognosis
• New functional assays to selectively quantify the activated protein C- and tissue factor pathway inhibitor-cofactor activities of protein S in plasma
• Oral contraception in women with mild thrombophilia: what have we learned recently?
• Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation
• Pediatric Thrombotic Events: Incidence, Clinical Risk Factors and Outcome
• Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation
• Polygenic risk scores and risk stratification in deep vein thrombosis
• Preeclampsia and thrombin generation test
• Pregnancy in a patient with hepatic artery thrombosis after liver transplantation: a case report
• Prevalence of the Factor V E666D Mutation and Its Correlation With Activated Protein C Resistance in the Chinese Population
• Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations
• Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population: The Rotterdam Study
• Pulmonary Embolism Despite Rivaroxaban in an Obese Patient
• Pulmonary embolism in Behcet's disease: a case report
• Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH
• Recurrent MiscarriageGreen-top Guideline No. 17
• Renal failure due to renal vein thrombosis in a fetus with growth restriction and thrombophilia
• Resistance to warfarin in a patient with hereditary thrombophilia
• Respirtory distress in newborns of mothers with factor V-Leiden thrombophilia
• Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation: a case report
• Spontaneous pregnancies in patients with at least one failed IVF cycle after the management of autoimmune disorders, hereditary thrombophilia, and methylation disorders
• Successful Living-Related Renal Allograft in a Recipient With Factor V Leiden Deficiency: A Case Report
• Successful treatment of cerebral venous sinus thrombosis with the Solitaire FR thrombectomy device
• Successful treatment of cerebral venous sinus thrombosis with the Solitaire FR thrombectomy device
• Sudden hearing loss followed by deep vein thrombosis and pulmonary embolism in a patient with factor V Leiden mutation
• Surgical treatment of impending paradoxical embolization associated with pulmonary embolism in a patient with heterozygosis of factor V Leiden
• Tamoxifen induces resistance to activated protein C
• Testing for Factor V Leiden (FVL) and Prothrombin G20210A Genetic Variants
• The frequency of factor V Leiden and prothrombin G20210A mutations in Slovak and Roma (Gypsy) ethnic group of Eastern Slovakia
• The impact of activated protein C resistance on the patency of arteriovenous grafts for hemodialysis access
• The prognostic role of extended preoperative hypercoagulability work-up in high-risk microsurgical free flaps: a single-center retrospective case series of patients with heterozygotic factor V Leiden thrombophilia
• Thrombophilia screening in the routine clinical care of children with arterial ischemic stroke
• Thyroid function, activated protein C resistance and the risk of venous thrombosis in users of hormonal contraceptives
• Venous hypertensive encephalopathy secondary to venous sinus thrombosis and dural arteriovenous fistula
• Your patient needs antithrombotics: leg venous thrombosis : how to proceed?